Charles River Laboratories International (CRL) Share-based Compensation (2009 - 2025)

Charles River Laboratories International's Share-based Compensation history runs 17 years deep, the most recent figure standing at $17.6 million for Q4 2025.

• In Q4 2025, Share-based Compensation rose 2.3% year-over-year to $17.6 million; the TTM figure through Dec 2025 stood at $71.1 million (up 1.71% YoY), while the FY2025 annual figure was $71.1 million, up 1.71% from the prior year.
• Share-based Compensation was $17.6 million for Q4 2025 at Charles River Laboratories International, down from $23.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $23.3 million in Q3 2025 to a low of $13.1 million in Q1 2025.
• Historically, Share-based Compensation has averaged $17.9 million across 5 years, with a median of $17.2 million in 2021.
• The sharpest annual moves came in 2021 and 2025: Share-based Compensation surged 30.55% in 2021, then fell 21.53% in 2025.
• A 5-year view of Share-based Compensation shows it stood at $19.2 million in 2021, then gained by 15.03% to $22.1 million in 2022, then slipped by 11.55% to $19.5 million in 2023, then slipped by 11.71% to $17.2 million in 2024, then climbed by 2.3% to $17.6 million in 2025.
• The last three Share-based Compensation figures came in at $17.6 million (Q4 2025), $23.3 million (Q3 2025), and $17.0 million (Q2 2025), per Business Quant data.